AMGN
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F2526659&ei=knKaUpjmBeTX0QGcJA&usg=AFQjCNGQzz5p_0vLLInIx-e_6lFWzKhdBA
Amgen, Inc. Issues FY 2012 Guidance In Line With Analysts' Estimates
Tuesday, 24 Apr 2012 04:04pm EDT
Amgen, Inc. announced that it continues to expect 2012 total revenue to be in the range of $16.1-$16.5 billion, and adjusted earnings per share (EPS) to be in the range of $5.90-$6.15, excluding certain expenses related to acquisitions and cost-savings initiatives, non-cash interest expense associated with our convertible notes and certain other items. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $16.3 billion and EPS of $6.07 for fiscal 2012.Â 
